MMP13 (matrix metallopeptidase 13) is a zinc-dependent collagenase that plays a critical role in extracellular matrix degradation, particularly targeting type II collagen in cartilage 1. As the primary MMP involved in cartilage degradation, MMP13 demonstrates particular efficacy in cleaving type II collagen, making it a key mediator of cartilage destruction in osteoarthritis 1. The enzyme's expression is regulated through multiple pathways, including protein kinase D3 (PKD3) signaling, which modulates MMP13 expression in human chondrocytes through downstream effects on AP-1 transcription factors 2. MMP13 activity contributes significantly to articular cartilage breakdown, with proteolytic fragments detectable in both cartilage tissue and synovial fluid of osteoarthritis patients 3. Beyond cartilage degradation, MMP13 participates in inflammatory processes across various tissues, including periodontal disease where it serves alongside MMP-8 as a collagenase involved in periodontal tissue destruction 4. The enzyme's expression can be suppressed by regulatory factors such as the host defense peptide LL-37, which inhibits TNFα-mediated MMP13 production in bronchial epithelial cells 5. Additionally, MMP13 expression is subject to microRNA regulation, with miR-675 demonstrating opposing effects on MMP13 levels in articular chondrocytes 6. MMP13 has emerged as a potential diagnostic marker for ferroptosis-related processes in rheumatoid arthritis 7.